Detall de la convocatòria
Característiques
| Característica |
|---|
|
Objectiu de la convocatòria
This program supports independent investigators in conducting innovative research on Tumor Treating Fields, aiming to better understand its mechanisms of action and accelerate the development of new therapeutic strategies to expand cancer treatment options. |
|
Característiques principals
Research proposals must incorporate Inovitro and/or Inovivo systems. If the institution does not have an MTA with Novocure, the company will provide the system. Projects should investigate TTFields as a cancer therapy and may include 1) Basic and translational approaches, promoting the transition of TTFields in vitro work into in vivo systems, 2) Studies that link preclinical and clinical data, or 3) Studies with ability to translate into the clinic for cancer treatment. Projects focusing on the following areas are encouraged: |
|
Lloc de presentació
HMRIB and PSMAR staff who need more information should contact: Research Grants and Contracts Office. C/ Doctor Aiguader, 88. 08003 Barcelona. Tel.: 93.316.04.00. Carol Barnwell: [email protected] Ext.: 1670 Marta López: [email protected] Ext.: 1576 Júlia Vidal: [email protected] Ext.: 1736 |
|
Convocatòria (URL)
https://www.aacr.org/grants/aacr-novocure-cancer-research-grant-aacr-grants/ |
|
Requisits
|
|
Dotació
$350,000 |
|
Durada
3 years |
|
AVÍS IMPORTANT
The AACR requires applicants to complete an online LOI by 1:00 p.m. U.S. Eastern Time on the deadline date through the ProposalCentral website. |
Arxius
| Arxiu |
|---|
| 2026-Novocure-Research-Grant-PGs-Final-1.pdf |